Vol. 26 No. 2 (2009)

Sarcoidosis vasculitis and diffuse lung diseases

Published: 01-12-2009

Antioxidant therapy for idiopathic pulmonary fibrosis. A promising therapeutic prospect

H. Tomioka

83-84
- PDF (Italian)

Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry

E. Antòn, Á. Casanova, A. Xaubet, et al.

85-91
- PDF (Italian)
Fatigue in sarcoidosis: American versus Dutch patients

W.P.E. de Kleijn, M.D.P. Elfferich, J. De Vries, et al.

92-97
- PDF (Italian)
Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study

J. Choi, L.A. Hoffman, J.M. Sethi, et al.

98-109
- PDF (Italian)
Inhaled iloprost for sarcoidosis associated pulmonary hypertension

R.P. Baughman, M.A. Judson, E.E. Lower, et al.

110-120
- PDF (Italian)
Steroid-Sparing effects of pentoxifylline in pulmonary sarcoidosis

M.K. Park, J.R. Fontana, H. Babaali, et al.

121-131
- PDF (Italian)
Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia

T.J. Corte, R. Ellis, E.A. Renzoni, et al.

132-138
- PDF (Italian)

Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis

H. Biller, B. Ruprecht, K.I. Gaede, et al.

139-146
- PDF (Italian)
N-acetylcysteine inhibits TNF-a, sTNFR, and TGF-b1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro

A. Cui, Q. Ye, R. ulrich.costabel@ruhrlandklinik.uk.essn.de, et al.

147-154
- PDF (Italian)
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis

N.P. Barlo, C.H.M. van Moorsel, H.J.T. Ruven, et al.

155-161
- PDF (Italian)

Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis

M. Coudurier, N. Freymond, S. Aissaoui, et al.

162-166
- PDF (Italian)

Lupus pernio: a tale of four characters in search of a malady

O.P. Sharma, I.C. Papanikolaou

167-171
- PDF (Italian)